Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ratutrelvir in mild to moderate COVID-19
NCT07157007Phase 2Recruiting
- Sponsor
- Traws Pharma, Inc.
- Start
- Sep 2025
- Primary completion
- Feb 2026
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 2 trial of ratutrelvir in coronavirus disease 2019 (COVID-19), sponsored by Traws Pharma, Inc.. Started Sep 2025; status: recruiting.
02
Drugs
ratutrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07157007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07157007.